Carmat S.A. (ALCAR.PA)

Carmat S.A. (ALCAR.PA) — VMCI valuation read

ALCAR.PA prints VMCI 35/100 inside the Healthcare sector, where the median sits at 50. The 15-point below-median delta is the cleanest single-number summary of Carmat S.A.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On ALCAR.PA, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** ALCAR.PA trades at 26.0x earnings, 44% above the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 1.2x leaves covenant headroom; that is the risk line for Carmat S.A. on the trailing financials.

ALCAR.PA fell 1.4% over the trailing 7 days, with a -0.8% read on a 30-day basis.